Celldex Therapeutics, Inc. CLDX 26.15
Health Care · NASDAQ · Data as of 2026-06-26
Celldex Therapeutics, Inc. (CLDX) has delivered -11.9% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1958 of 1993 stocks overall and #256 of 264 in the Health Care sector by Steady Score.
Industry
Diagnostic Substances
Steady Score
26.15
Overall Rank
#1958 / 1993
Sector Rank
#256 / 264
Revenue CAGR
-11.9%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio